From Tissue Specificity to Systemic Cues: Shaping MYC-Driven Tumor Metabolism.

MYC-driven tumor metabolism varies with tissue type, microenvironment, and systemic factors, revealing context-dependent vulnerabilities that may inform targeted therapies.

• Why it matters: Understanding how MYC interacts with tissue-specific and systemic influences is crucial for developing precise treatments for MYC-driven cancers, which are highly adaptable.
• What they did: The review examines in vivo MYC-driven metabolic programs, focusing on tissue-specific activities, tumor microenvironment interactions, and systemic influences like diet and metabolism, to identify metabolic vulnerabilities.
• The result: Insights into MYC-dependent metabolic reprogramming may enable the discovery of actionable targets and guide personalized therapeutic strategies for MYC-driven tumors.